UK markets closed

eFFECTOR Therapeutics, Inc. (EFTR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.2901-0.0199 (-6.42%)
At close: 04:00PM EDT
0.2890 -0.00 (-0.38%)
After hours: 07:52PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-34,631
-35,811
-22,665
15,798
14,211
Depreciation & amortisation
111
111
53
24
160
Stock-based compensation
4,438
4,595
5,334
8,660
499
Change in working capital
954
1,685
2,677
-238
-824
Accounts payable
-2,086
855
958
155
-251
Other working capital
-29,275
-29,647
-26,091
-24,930
13,681
Other non-cash items
354
346
-10,624
-48,593
122
Net cash provided by operating activities
-29,191
-29,550
-25,899
-24,888
13,835
Cash flows from investing activities
Investments in property, plant and equipment
-
-97
-192
-42
-154
Purchases of investments
-24,030
-17,169
-52,418
0
-
Sales/maturities of investments
23,250
31,750
34,750
0
-
Net cash used for investing activities
-864
14,484
-17,860
565
-154
Cash flows from financing activities
Debt repayment
-
-
0
-13,940
-2,000
Common stock issued
35,752
21,177
2,799
0
-
Other financing activities
-
-
-37
52,858
-
Net cash used provided by (used for) financing activities
35,253
21,233
2,765
58,809
-1,892
Net change in cash
5,198
6,167
-40,994
34,486
11,789
Cash at beginning of period
10,310
8,708
49,702
15,216
3,427
Cash at end of period
15,508
14,875
8,708
49,702
15,216
Free cash flow
Operating cash flow
-29,191
-29,550
-25,899
-24,888
13,835
Capital expenditure
-
-97
-192
-42
-154
Free cash flow
-29,275
-29,647
-26,091
-24,930
13,681